Table 2 of Zhou, Mol Vis 2012; 18:309-316.


Table 2. Clinical features of carriers with CHM.



Patient
Age
of
test


Symptoms and signs
F1-II-2 45 hypopigment changes in the midperiphery area fine RPE mottling patchy areas of chorioretinal atrophy (Figure 7A)
F2-II-2 71 NA; Fundus: diffuse punctate hypopigmentary changes (Figure 7B)
F2-II-3 67 NA; Fundus: diffuse punctate hypopigmentary changes
F3-II-2 69 Decreased vision
Refraction:OD 0–3.50×130 20/60; OS +0.50+1.25×40 20/30;
Fundus: see Figure 7C
ERG: reduced rod and cone amplitude
VF: constricted, central 20° VF
F3-IV-1 17 Refraction; OD −1.25–0.75×160 20/20; −1.00–1.00×8 20/20